{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T07:02:27Z","timestamp":1790406147829,"version":"4.1.0"},"reference-count":0,"publisher":"American Society for Clinical Investigation","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Clin. Invest."],"published-print":{"date-parts":[[1997,6,1]]},"DOI":"10.1172\/jci119455","type":"journal-article","created":{"date-parts":[[2008,2,29]],"date-time":"2008-02-29T17:25:05Z","timestamp":1204305905000},"page":"2664-2671","source":"Crossref","is-referenced-by-count":191,"title":["Increased CD80(+) B cells in active multiple sclerosis and reversal by interferon beta-1b therapy."],"prefix":"10.1172","volume":"99","author":[{"given":"K","family":"Gen\u00e7","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D L","family":"Dona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A T","family":"Reder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"232","container-title":["Journal of Clinical Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.jci.org\/articles\/view\/119455\/files\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,3]],"date-time":"2023-08-03T16:33:45Z","timestamp":1691080425000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jci.org\/articles\/view\/119455"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,6,1]]},"references-count":0,"journal-issue":{"issue":"11","published-print":{"date-parts":[[1997,6,1]]}},"URL":"https:\/\/doi.org\/10.1172\/jci119455","relation":{},"ISSN":["0021-9738"],"issn-type":[{"value":"0021-9738","type":"print"}],"subject":[],"published":{"date-parts":[[1997,6,1]]}}}